Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism

BMC Pediatrics

Volumn 2, Issue , 2002, Pages

  Scaglia, Fernando ^a   Scheuerle, Angela E ^b,c   Towbin, Jeffrey A ^a   Armstrong, Dawna L ^a   Sweetman, Lawrence ^d   Wong, Lee Jun C ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dept Genet Teratol/Ethics Consult ^*  (United States)

^c North Texas March of Dimes Birth Defects Center   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 Methylglutaconic aciduria; Mitochondrial dysfunction; Reye like syndrome; Ventricular tachycardia

Indexed keywords

3 METHYLGLUTACONIC ACID; ACETIC ACID; ACYLCARNITINE; ARGININE; BENZOIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOXYLIC ACID; CARNITINE ACYLTRANSFERASE; FATTY ACID; GLUCOSE; OROTIC ACID; PHENYLACETIC ACID; 3-METHYLGLUTACONIC ACID; BIOLOGICAL MARKER; CARNITINE; DRUG DERIVATIVE; GLUTARIC ACID DERIVATIVE; MITOCHONDRIAL DNA;

ACIDURIA; AGE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME DEFICIENCY; FATIGUE; FATTY ACID OXIDATION; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERAMMONEMIA; HYPERTROPHIC CARDIOMYOPATHY; HYPOGLYCEMIA; INFECTION; LABORATORY TEST; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NEWBORN PERIOD; PHENOTYPE; PROTEIN RESTRICTION; RECURRENT DISEASE; REYE SYNDROME; SCHOOL CHILD; URINALYSIS; GENETICS; METABOLISM; MITOCHONDRIAL MYOPATHY; MUTATION; NEWBORN; URINE;

BIOLOGICAL MARKERS; CARNITINE; DNA, MITOCHONDRIAL; FEMALE; GLUTARATES; HUMANS; INFANT, NEWBORN; MITOCHONDRIAL MYOPATHIES; MUTATION; OROTIC ACID; REYE SYNDROME; TACHYCARDIA, VENTRICULAR;

EID: 2642562118     PISSN: 14712431     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2431-2-12     Document Type: Article

References (39)

1. Holt IJ, Harding AE and Morgan HJA Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719
2. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJD and Nikoskelainen EK Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430
3. Liang M-H and Wong L-JC Yield of mtDNA mutation analysis in 2000 patients. Am J Med Genet 1998, 77:395-400
4. Von Kleist-Retzow J-C, Cormier-Daire V, de Lonlay P, Parfait B, Chretien D, Rustin P, Feingold J, Rotig A and Munnich A A high rate (20-30%) of parental consanguinity in cytochrome oxidase deficiency: Am J Human Genet 1998, 63:428-43
5. King TE and Howard RL Preparation and properties of NADH dehydrogenase from cardiac muscle. In: Methods in Enzymology: Oxidation and Phosphorylation (Edited by: Estabrook R, Pullman M) New York, Academic Press 1967, 275-294
6. King TE Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Methods in Enzymology: Oxidation and Phosphorylation (Edited by: Estabrook R, Pullman M) New York, Academic Press 1967, 322-331
7. Yonetan T Cytochrome oxidase: Beef heart. In: Methods in Enzymology: Oxidation and Phosphorylation (Edited by: Estabrook R, Pullman M) New York, Academic Press 1967, 332-335
8. Srere PA Citrate synthase. In: Methods in Enzymology: Oxidation and Phosphorylation (Edited by: Lowenstein J) New York, Academic Press 1969, 3-11
9. Wong L-JC and Bai R Real time quantitative PCR analysis of mitochondrial DNA in patients with mitochondrial disease. Am J Human Genet 2002, 71(suppl):S499
10. Glasgow JF and Middleton B Reye syndrome-insights on causation and diagnosis. Arch Dis Child 2001, 85:351-353
11. Treem WR Inherited and acquired syndromes of hyperammonemia and encephalopathy in children. Semin Liver Dis 1994, 14:236-258
12. Hou J-W and Wang TR 3-methylglutaconic aciduria presenting as Reye syndrome in a Chinese boy. J Inherit Metab Dis 1995, 18:645-646
13. Hou J-W, Chou S-P and Wang T-R Metabolic function and liver histopathology in Reye-like illness. Acta Paediatr 1996, 85:1053-1057
14. Bonnet D, Martin D, de Lonlay P, Villain E, Jouvet P, Rabier D, Brivet M and Saudubray J-M Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders. Circulation 1999, 100:2248-2253
15. Pande SV Carnitine-acylcarnitine translocase deficiency. Am J Med Sci 1999, 318:22-27
16. Drachman DA Ophthalmoplegia plus: the neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 1968, 18:654-674
17. Berenberg RA, Pellock JM, DiMauro S, Schotland DL, Bonilla E, Eastwood A, Hays A, Vicale T, Behrens M, Chutorian A and Rowland LP Lumping or splitting? 'Ophthalmoplegia-plus' or Kearns-Sayre syndrome? Ann Neurol 1977, 1:37-54
18. Biard F, Philippe C, Berrut G, Lardy B and Slama R Kearns-Sayre syndrome:complete auriculovertebral block, torsade de pointes and ventricular fibrillation. Ann Cardiol Angeiol 1988, 37:529-534
19. Gibson KM, Elpeleg ON, Jakobs C, Costeff H and Kelly RI Multiple syndromes of 3-methylglutaconic aciduria. Pediatr Neurol 1993, 9:120-123
20. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis P-A and Toniolo D A novel X-linked gene, G4.5 is responsible for Barth syndrome. Nat Genet 1996, 12:385-389
21. Elpeleg ON, Costeff H, Joseph A, Shental I, Weitz R and Gibson KM 3-methylglutaconic aciduria in the Iraqi Jewish 'optic atrophy plus' (Costeff) syndrome. Dev Med Child Neurol 1994, 36:167-172
22. Anikster Y, Kleta R, Shaag A, Gahl WA and Elpeleg O Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet 2001, 69:1218-1224
23. Gibson KM, Bennett MJ, Mize CE, Jakobs C, Rotig A, Munnich A, Lichter-Konecki U and Treftz FK 3-methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr 1992, 121:940-942
24. Scaglia F, Sutton VR, Bodamer OAF, Vogel H, Shapira SK, Naviaux RK and Vladutiu GD Mitochondrial DNA depletion associated with partial complex II and IV deficiencies and 3-methylglutaconic aciduria. J Child Neurol 2001, 16:136-138
25. Ibel H, Endres W, Hadorn HB, Deufel T, Paetzke I, Duran M, Kennaway NG and Gibson KM Multiple respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-methylglutaconic aciduria. Eur J Pediatr 1993, 152:665-670
26. Figarella-Branger D, Pellissier JF, Scheiner C, Wernert F and Desnuelle C Defects of the mitochondrial respiratory chain complexes in three pediatric cases with hypotonia and cardiac involvement. J Neurol Sci 1992, 108:105-113
27. Kelley RI and Kratz L 3-Methylglutaconic acidemia in Smith-Lemli-Opitz syndrome. Pediatr Res 1995, 37:671-674
28. Corona P, Lamantea E, Greco M, Carrara F, Agostino A, Guidetti D, Dotti MT, Mariotti C and Zeviani M Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentation. Ann Neurol 2002, 51:118-122
29. Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P and Lodi R Very low levels of the mtDNA A3243G mutation is associated with mitochondrial dysfunction in vivo. Ann Neurol 2000, 47:381-384
30. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I and Bertorini TE Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive disorder. Neurology 1994, 44:721-727
31. Sternberg D, Danan C, Lombes A, Laforet P, Girodon E, Goossens M and Amselem S Exhaustive scanning approach to screen all the mitochondrial tRNA genes for mutations and its application to the investigation of 35 independent patients with mitochondrial disorders. Human Molecular Genetics 1998, 7:33-42
32. Liang M-H and Wong L-JC Novel nucleotide substitutions in mitochondrial DNA. J Inherit Metab Dis 1998, 21:871-873
33. Shoffner JM and Wallace DC Oxidative phosphorylation diseases. In: The Metabolic and Molecular Bases of Inherited Disease (Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D) New York, McGraw-Hill 1999, 1535-1629
34. Mitomap Database
35. Bonham JR, Guthrie P, Downing M, Allen JC, Tanner MS, Sharrard M, Rittey C, Land JM, Fensom A, O'Neill D, Duley JA and Fairbanks LD The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. J Inherit Metab Dis 1999, 22:174-184
36. Parfait B, de Lonlay P, von Kleist-Retzow JC, Cormier-Daire V, Chretien D, Rotig A, Rabier D, Saudubray JM, Rustin P and Munnich A The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. Eur J Pediatr 1999, 158:55-58
37. Rabier D, Diry C, Rotig A, Rustin P, Heron B, Bardet J, Parvy P, Ponsot G, Marsac C, Saudubray JM, Munnich A and Kamoun P Persistent hypocitrullinaemia as a marker for mtDNA NARP T 8993 G mutation? J Inherit Metab Dis 1998, 21:216-219
38. KG Sim, Carpenter K, Hammond J, Christodoulou J and Wilcken B Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders. Metabolism 2002, 51:366-371
39. Scholte HR, Busch HF, Luyt-Houwen IE, Vaandrager-Verduin MH, Przyrembel H and Arts WF Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells. J Inherit Metab Dis 1987, 10(Suppl 1):81-97